A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 9/21/2011

Posted by | 11:26pm on Wednesday, September 21, 2011

:
Welcome to the #pharma marketing & social media chat (#socpharm). Plse start w/intros & why u are interested in this.

:
I’m Heather Powell, in Business Practices and Ethics at DSI. Welcome! #socpharm

:
We’ll assume that all tweets within #socpharm are your own and not your employers (unless you specifically declare them).

:
Hi all. Frieda Hernandez hre from Siren Interactive tuning in 4 #socpharm. interested in all things #raredisease #fdasm #epatient #epharma

:
@: Welcome, looking forward to your moderating #socpharm

:
Maybe everyone is wiped out from #epatcon! Hi Frieda — anyone else out there? #socpharm

:
Unfortunately I missed it. RT @: : Maybe everyone is wiped out from #epatcon! Hi Frieda — anyone else out there? #socpharm

:
Hi Heather. Ciaran Bellwoar from Siren Interactive. Looking forward to good conversations tonight at #socpharm

:
Hi – Chuck Strand from Siren here. #socpharm

:
Well, I’ll plow ahead with our first topic, one of great interest to me! #socpharm

:
Drug firm payments to doctors declining: ProPublica has posted an update to their previous study of pharma pmts to HCPs. #socpharm

:
@: @: #socpharm i’m here for a few minutes, lurking, mom, mental health advocate interested in pharma transparency

:
Hi Ciaran, Chuck, @: ! What do you think is behind decline in payments? Is it the companies or HCPs who are hesitant? #socpharm

:
Big thanks to @: for moderating #socpharm while I’m speaking to #HBA on social media.

:
#socpharm i personally like the ProPublica database, its a great beginning to the sunshine act. #pharma should be accountable on websites

:
Here’s a link to an article detailing the updated findings: http://t.co/GFcPYdtG #socpharm

:
and Lilly has pretty good transparency on their site #socpharm also AstraZeneca has began theirs, adding some as result of DoJ conditions

:
Did they cite reasons? @: : re Drug firm payments to MDs declining: ProPublica posted an update to previous study #socpharm

:
I know that those of us inside pharma who are responsible for Sunshine reporting wish that HHS would issue their regs already! #socpharm

:
#socpharm well the direct payment to physicians could be lower but the other entities are not, some are where docs work, Yale, Mass Gen..

:
Lilly’s database for grants awarded shows a LOT of hospitals, advocacy grp such as NAMI and Chadd, inc all asking for $$ #socpharm

:
Frieda, big focus on academic med centers restricting speaking by their physicians, as well as companies cutting spkr bureaus. #socpharm

:
@: I heard non-speaking drs are looking for more Thought Leaders than paid KOLs – at least in online communities #socpharm

:
@: The power of transparency! #socpharm

:
#socpharm so what the lower stats on docs getting $ show is that the money is being sent to agencies,institutions,etc & docs indirectly bene

:
@: Sometimes non-profits are actually providing services to patients, collecting fees from pharma, e.g: NAMI #socpharm

:
@: #socpharm i was shocked at Dr. Melissa DelBello at University of Cinncinati getting $215K for Q1 from Lilly!!

:
@: yes #socpharm NAMI receives 75% funding frm pharma.Prob is, they call themselves grassroots org type…and are Pro-med mission

:
@: I think the Sunshine act it good overall for sake of transparency. Not sure it’s wrong for docs to accept $$ #socpharm

:
@: #socpharm I guess another Q could be if doctors take less pharma money because of the new database and sunshine act exposure

:
@: How does this impact MDs participating in pharma funded dlinical trials as investigators? #socpharm

:
I believe there will always be a place for legitimate services by HCPs for pharma. Not sure if spkr programs will be that place! #socpharm

:
it’s wrong to take the pharma $ as a doctor if the doc takes $ from the same co that funds a clinical trial… #socpharm #ethics

:
PIs and CROs are having the most trouble adjusting to Sunshine, I think. Perception that legit research should be sep from promo. #socpharm

:
@: IMO speakers play a very important role #socpharm

:
It would be interesting to get stats on patient/caregiver views of docs accepting fees; what terms/situations may be acceptable. #socpharm

:
@: @: #socpharm i dont think the doc should be paid by or the trials funded by pharma cos w control of data #ethics

:
MT @: @: IMO Sunshine act it good overall for sake of transparency. Unsure its wrong for docs to accept $$ #socpharm

:
variety of reasons for drop in spending, including life cycle of meds #socpharm

:
i know @ has mentioned one #socpharm chat that the Sunshine act has impacted his clinical trial business

:
@: #socpharm drop in meds, meaning patent expiry? (cliffs)?

:
Hi Heather. Darshan from the Kulkarni Law Firm. Excited to join in #socpharm :) #socpharm

:
CROs are not used to providing HCP-level pmts back to pharma. Major change in philosophy, systems and business model. #socpharm

:
Hi Darshan and Tony! Welcome. #socpharm

:
@: Does Sunshine just cover promo $ or compensation for any pharma funded activity indluding research? #socpharm

:
Sunshine covers pmts to physicians and teaching hospitals for both promo and clinical research. #socpharm

:
@: A lot of CROs are not prepared for this. #socpharm

:
Clinical trial pmt reporting is delayed to protect intellectual property. #socpharm

:
@: i’m a patient advocate and caregiver, you can measure n=1 from my tweets :) #socpharm

:
@: @ All payments #socpharm

:
@: I do think there can be an influence but more like what gets published re: data from trials #socpharm #ethics

:
Any other thoughts on Sunshine, transparency or conflicts of interest before we move on? #socpharm

:
@: perhaps, but not necessarily. more mature meds with no new indications=less need #socpharm

:
@: #socpharm yes if we can trust the data published, as some have not been forthright in some instances, internal docs show

:
@: How long r ur delays typically (often internal policies) #socpharm

:
@: @: Now there’s a valid stat! #socpharm

:
T2: @ mentioned that at HBA mtg last week, consolidation of pharma companies was a topic of discussion. #socpharm

:
Interesting RT @: : CROs R not used 2 providing HCP-level pmts back 2 pharma. Major change in…business model. #socpharm

:
IMO I think the transparency has gotten a little out of line #socpharm

:
T2: Where do you think industry will be in 5 years? 10 mega companies, biotechs, a mix? #socpharm

:
Yes, I recall reading that now. RT @: : Clinical trial pmt reporting is delayed to protect intellectual property. #socpharm

:
@: Do you mean delays in reporting? It’s statutory for Sunshine. #socpharm

:
@: ahh no wonder certain meds are in so many trials for expanded indication! what some call ‘patent extenders’ #socpharm

:
Hello #socpharm. Joining late but happy to be here.

:
We luv having yr views RT @: : @: i’m a patient advocate & caregiver, U cn measure n=1 from my tweets :) #socpharm

:
Dollars for Docs. http://t.co/KOhVPG2W Eager for your thoughts. #socpharm @:

:
@: T2 #socpharm more Q are the loss of blockbuster drugs to generic/patent expiry going to change outlook for next 5 yrs?

:
Welcome! Charles, I am a huge fan of transparency and appreciate the context that is being offered, which is critical. #socpharm

:
@: sorry: clarification: What outlook for big pharma/small/biotech? #socpharm

:
I am very concerned about HHS’s ability to provide appropriate context to end users for a huge amount of sensitive data. #socpharm

:
Personally, I feel bad for the docs. Its asking for very personal info. Like asking my salary. Not sure I would like that. #socpharm

:
T2: IMHO there will be 10 megas and a lot of biotech start-ups. I think the middle is getting squeezed in pharma #socpharm

:
I’m wondering if big pharma will continue to consolidate/downsize and what role small companies will play, esp in research. #socpharm

:
MT @: : I am concerned about HHS’ ability to provide appropriate context 4 a huge amount of sensitive data. #socpharm

:
Darshan, we were just talking about that in a meeting today. We don’t reveal our W2s to the world! #socpharm

:
We try to provide context in terms of products made by each co. and descriptions of services each co. uses #socpharm

:
@: #socpharm many public servant jobs such as teachers have income/earnings posted in public database, as well as state paid docs

:
@: Do you think there might be a split completely: R&D companies and those that commercialize? #socpharm

:
I think it’s entirely possible, Ciaran. We’re already seeing a lot of partnerships in that vein, esp in personalized medicine. #socpharm

:
@: But not at an individual level, but at a block level. I remember, coz I clerked for a fed judge. #socpharm

:
@: My salary was same as others of my “block”. But no one really asked me my specific block. That would be rude. #socpharm

:
I think taxpayers feel they have a right to know salaries of publicly-funded employees. Should that extend to HCPs, too? #socpharm

:
@: well the docs are having to produce W-2′s just that income from pharma inc travel/meals, the rest is private (i think) #socpharm

:
@: some school districts post ALL employee income, i found that interesting and lacking privacy #socpharm

:
I am loving this conversation! Here’s a hypothetical: if PPACA gets repealed, should Sunshine still live on? #socpharm

:
@: i meant NOT produce w-2s just pharma income! #socpharm (typo)

:
@: @: Payments from pharma for speaking, etc., not quite the same as salaries, IMHO #socpharm

:
The amount of an HCP’s salary is irrelevant; the potential problem is the source, right? #socpharm

:
@: @: @: Why? Its another source of income. #socpharm

:
RT @: Map tracks antibiotic-resistant ‘superbugs’ online http://t.co/7qF3wgdr #mhealth #ehealth #hcsm #hcsmca #hcsmla #fdasm #socpharm #ehr #emr

:
@: Exactly #socpharm

:
The potential problem is the conflict between commitment to objective patient care and financial influence from pharma. #socpharm

:
@: #socpharm

:
@: @: @: #socpharm why disclose only pharma income? not personal salary? because its not required in sunshine

:
RT @: The potential problem is the conflict between commitment to objective patient care and financial influence from pharma. #socpharm

:
@: are they that closely married? if PPACA gets repealed, should Sunshine still live on? #socpharm

:
@: Agreed. But, the question is whether pt. care is affected or costs are affected. Different questions IMO. #socpharm

:
Because of potential to influence prescribing? RT @: : @: @: Why? Its another source of income. #socpharm

:
@: @: @: @: Exactly, but IMO the sunshine act goes too far. #socpharm

:
@: yes, exactly #socpharm the doctor speaks on a certain drug, gets income frm that company, writes scrip to patient= COI

:
I think R&D cos r incubators for big Rx to buy RT @: : @: Yes, split between R&D cos & those that commercialize #socpharm

:
Sunshine was passed as section of PPACA. If PPACA repealed, Sunshine would have to pass on its own. #socpharm

:
@: @: I concede my bias. My wife is doc, and I hate that in the future her income is up 4 world #socpharm

:
@: But speaking on topic =/= bias. Just that he delivered a service and got paid for it. #socpharm

:
OMG! Don’t want to think abt it. @: : re: if PPACA gets repealed, should Sunshine still live on? #socpharm

:
@: I think thats already happening. #socpharm

:
@: @: #socpharm ohh now that’s transparency! and explains your personal bias! good to know why we say what we do

:
I’m still eagerly awaiting those regs, allegedly to us by October 1. Not holding my breath. #socpharm

:
Agreed RT @: : @: I think thats already happening. #socpharm

:
thanks for moderating! i’ve got to run, thanks for the discussion everyone! @: #socpharm

:
Good night @: ! Thanks for joining! #socpharm

:
OK, we’ve got a few minutes left. Let’s talk about texting! #socpharm

:
@: Always great to have you in the convo. #socpharm

:
@: Thx for the convo #socpharm

:
what happens if regs delayed? #socpharm

:
Yes, but it may become a necessary norm vs a trend RT @: : Agreed RT @: : @: I think thats already happening. #socpharm

:
MT @: : Potential problem is conflict b/w commitment to objective patient care and financial influence from pharma. #socpharm

:
Pew Research came out with a new report on Americans and texting: http://t.co/vM6zLeUq #socpharm

:
@: IMO I have been seeing it for a few years. May get worse. But big pharma is better at marketing worse at research #socpharm

:
Charles, it’s not clear. Would hope for a delay in implementation until we have regs, but proceeding w/what we know in interim. #socpharm

:
@: I agree with that too. Many smaller companies more nimble with research. Big pharma seeing diminishing returns for R&D $ #socpharm

:
I look at how my teen texts-primary comm channel RT @: : OK, we’ve got a few minutes left. Let’s talk about texting! #socpharm

:
Is it possible for pharma companies to meaningfully provide info/promo via text? #socpharm

:
@: I think as with any medium, if user says preferred way of comm, it can be used #socpharm

:
For compliance…great reminder @: : Is it possible for pharma companies to meaningfully provide info/promo via text? #socpharm

:
As long as they’re adding value. #socpharm

:
@: #socpharm Hi Heather – chiming in late. Yes, SMS can be powerful – studies starting to show its #behaviorchange benefits.

:
Depends on what the info is. #socpharm

:
@: Not to me, I’m old school, in the 53% who prefer voice :-) Probably depends on value of the message #socpharm

:
I know that I would be happy to get reminder texts about taking meds. I can’t remember where my keys are at any given moment! #socpharm

:
@: Issues with HIPAA potentially #socpharm

:
Agreed RT @: : @: I think as with any medium, if user says preferred way of comm, it can be used #socpharm

:
I guess it’s like any other medium — make sure it’s not just more noise, not adding value to the user’s life. #socpharm

:
@: Hey Jeff. How goes it. #socpharm

:
TXT is immediate, great attention-getter. Need opt-in, but allows for follow-up (value-added of course) via other channels #socpharm

:
Anything else anyone would like to tee up before the hour is over? This time goes so fast! #socpharm

:
@: LOL!!! They can definitely text me about my keys! #socpharm

:
Pros for SMS: fast delivery, can add image – quick how-to infographic for self-administered meds #socpharm

:
Great idea! RT @: : Pros for SMS: fast delivery, can add image – quick how-to infographic for self-administered meds #socpharm

:
Questions like: How did pharma get the info would be raised. #socpharm

:
Must be permission-based, like email. RT @: : Questions like: How did pharma get the info would be raised. #socpharm

:
RT @: : Pew Research came out with a new report on Americans and texting: http://t.co/vM6zLeUq #socpharm

:
And SMS has a 75-80% reach that’s relatively cheap .. your app can’t do that. #socpharm

:
Not sure pharma could do a permission based email reminder either. Would need to check specifically. #socpharm

:
Hi Jeff. Good point for all mobile RT @: : And SMS has a 75-80% reach that’s relatively cheap .. your app can’t do that. #socpharm

:
@: What do you think Heidi? PR/legal/reg problems with SMS reminders? #socpharm

:
I think that with appropriate safeguards and ISI where necessary, opt-in reminders could be OK. #socpharm

:
And that’s the hour! Thanks again to @ for inviting me to moderate tonight. She’ll have the transcript up this week. #socpharm

:
@: We should talk more about that next time around. #socpharm

:
And for anyone who likes to idly chat about Sunshine or transparency or whatever, please feel free to reach out to me! #socpharm

:
Thanks to @: for guest moderating #socpharm I’ll post the transcript tomorrow.

:
Hear hear! RT @: I think that with appropriate safeguards and ISI where necessary, opt-in reminders could be OK. #socpharm

:
@: @: @: @: @: @ Great chatting with you, must sign off. #socpharm

:
Thanks again to everyone for participating tonight! See you next week. #socpharm

:
SMS reminders used for Guardasil boosters in Australia to aid compliance. Was successful. #socpharm

:
Night #socpharm, thanks #heldincontempt: .

:
@: Rocking convo, you’re an awesome moderator, Heather! #socpharm

:
Thanks for hosting! Good night. #socpharm

:
@: @: @: @: @: @: @: @ Good conversation for sure. #socpharm

:
RT @: : @: @: @: @: @: @: @ Thx all #socpharm

:
Thanks, everyone! @: @: @: @: @: @ @ @: #socpharm

:
RT @: : @: @: @: @: @: @: @: @ Good conversation for sure. #socpharm

:
Will try to set my alarm earlier for next week’s #socpharm :) G’night all

:
Great context for a complicated issue: About the Dollars for Docs Data – ProPublica http://t.co/Q1prx4ku via @ #socpharm #in

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

2 Pingbacks/Trackbacks

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com